Necrotic ulcerations of cutaneous vasculitis in rheumatoid arthritis: Treatment with anti-TNFα;Vasculite avec ulcérations cutanées au cours de la polyarthrite rhumatoïde: Traitement par anti TNFδ

Annales de Dermatologie et de Venereologie

Volumn 133, Issue 5 I, 2006, Pages 453-455

  Thirion, L ^a   Picard, D ^a   Mejjad, O ^a   Courville, P ^a   Le Loet, X ^a   Joly, P ^a,b  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CYCLOPHOSPHAMIDE; INFLIXIMAB; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ARTICLE; CASE REPORT; CLINICAL FEATURE; COURSE EVALUATION; DISEASE COURSE; DRUG TREATMENT FAILURE; HUMAN; LEG ULCER; RELAPSE; RHEUMATOID ARTHRITIS; SKIN NECROSIS; SKIN ULCER; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; VASCULITIS;

EID: 33747682292     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0151-9638(06)70938-3     Document Type: Article

References (11)

1. Brousse C. Les inhibiteurs du TNF. Rev Med Interne 2003;24:123-6.
2. Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999;340:1398-405.
3. Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 2000;342:763-9.
4. Maksymowych WP, Jhangri GS, Lambert RG, Mallon C, Buenviaje H, Pedrycz E, et al. Infliximab in ankylosing spondylitis : a prospective observational inception cohort analysis of efficacy and safety. J Rheumatol 2002;29:959-65.
5. Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ. Etanercept in the treatment of psoriatic arthritis and psoriasis : a randomised trial. Lancet 2000;356:385-90.
6. Sfikakis PP. Behçet's disease: a new target for anti-tumour necrosis factor treatment. Ann Rheum Dis 2002;61:51-3.
7. Triolo G, Vadala M, Accardo-Palumbo A, Ferrante A, Ciccia F, Giardina E, et al. Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behcet's disease. Ann Rheum Dis 2002;61:560-1.
8. Bartolucci P, Ramanoelina J, Cohen P, Mahr A, Godmer P, Le Hello C, Guillevin L. Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients. Rheumatology 2002;41:1126-32.
9. Lamprecht P, Voswinkel J, Lilienthal T, Nolle B, Heller M, Gross WL Gause A. Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis. Rheumatology 2002;42:1303-7.
10. Arbach O, Gross WL, Gause A. Treatment of refractory Churg-Strauss- Syndrome (CSS) by TNF-alpha blockade. Immunobiology 2002;206:496-501.
11. Unger L, Kayser M, Nusslein HG. Successful treatment of severe rheumatoid vasculitis by infliximab. Ann Rheum Dis 2003;62:587-8.